Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health
It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment
It helps nerves send signals. Who Needs B12 Supplementation Some groups are more likely to need B12 supplements
Research suggests BPC-157 has a favorable safety profile in clinical studies, though individual responses may vary
Very fast thanks So far the medication is great